Search Results 121-130 of 16178 for VEO-IBD

  1. Medical Research & Education - Mayo Clinic News Network

    What is inflammatory bowel disease? Jennifer O'Hara. April 25, 2019. Majority of U.S. ...

  2. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis - Mayo Clinic

    ... colitis (UC). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

  3. A Placebo-Controlled Trial of Pregabalin (Lyrica) for Irritable Bowel Syndrome - Mayo Clinic

    Known alternative/concurrent gastrointestinal diagnosis (e.g. Crohn's disease, ulcerative colitis, microscopic colitis, active celiac sprue, chronic ...

  4. Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) - Mayo Clinic

    Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) · Overview · Participation ...

  5. Medical Research & Education - Mayo Clinic News Network

    What is inflammatory bowel disease? Jennifer O'Hara. April 25, 2019. Majority of U.S. ...

  6. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

    To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...

  7. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) learning health system approach that enables patients ...

  8. Intestinal Obstruction Clinical Trials - Mayo Clinic Research

    ... inflammatory bowel disease (IBD),post-surgical patients with an increased risk of developing paralytic postoperative ileus (POI), and patients with evidence ...

  9. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

    Clinical Trials · A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK- ...

  10. Medical Research & Education - Mayo Clinic News Network

    What is inflammatory bowel disease? Jennifer O'Hara. April 25, 2019. Majority of U.S. states restrict ...